Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
GLP-1 RAs are preferred second-line agents in patients with T2DM with established atherosclerotic cardiovascular diseases (ASCVD) in light of their demonstrated ASCVD benefit, high efficacy, low potential for hypoglycaemia and potential for weight loss
Deciding to use GLP-1/GIP for weight loss should always involve careful advice from your doctor
Studies show Retatrutide users losing up to 24% of body weight compared to Tirzepatides 15-22% over similar periods
[4] After only a few years on the market, thousands of Ozempic and Wegovy users reported experiencing gastrointestinal issues to the FDA
Avoid shaking during reconstitution
US$ 26.05
US$ 25.20
US$ 28.82
US$ 22.57
US$ 29.91
US$ 25.01
US$ 22.37
US$ 24.37
